ArticleCureus2026
A Persistent Pneumonia or an Uncommon Condition: A Case of Immunotherapy-Induced Pneumonitis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immunotherapy with immune checkpoint inhibitors has revolutionized the treatment of metastatic renal cell carcinoma. However, it may be associated with severe toxicity, particularly immune-mediated pneumonitis. The present case report describes a 60-year-old patient diagnosed with stage IV clear cell renal carcinoma undergoing treatment with nivolumab, who developed severe partial respiratory failure refractory to empirical antibiotic therapy. After exclusion of other causes, namely, cardiovascular and infectious etiologies, immune-mediated pneumonitis was suspected, and systemic corticosteroid therapy was initiated, resulting in significant clinical and radiological improvement. This case illustrates immune-mediated pneumonitis in the context of nivolumab treatment, highlighting the importance of an accurate differential diagnosis in patients receiving immunotherapy and the early initiation of corticosteroid therapy when immune-related pneumonitis is suspected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.